| PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+ CD38 hi cells and anti-PD-1 resistance V Verma, RK Shrimali, S Ahmad, W Dai, H Wang, S Lu, R Nandre, P Gaur, ... Nature immunology 20 (9), 1231-1243, 2019 | 264 | 2019 |
| Integrin CD11b activation drives anti-tumor innate immunity MC Schmid, SQ Khan, MM Kaneda, P Pathria, R Shepard, TL Louis, ... Nature communications 9 (1), 5379, 2018 | 245 | 2018 |
| Radiation, immune checkpoint blockade and the abscopal effect: a critical review on timing, dose and fractionation ZS Buchwald, J Wynne, TH Nasti, S Zhu, WF Mourad, W Yan, S Gupta, ... Frontiers in oncology 8, 612, 2018 | 178 | 2018 |
| Metabolic cooperation and competition in the tumor microenvironment: implications for therapy S Gupta, A Roy, BS Dwarakanath Frontiers in oncology 7, 68, 2017 | 174 | 2017 |
| Role of tumor necrosis factor-α and TRAIL in high-dose radiation–induced bystander signaling in lung adenocarcinoma MM Shareef, N Cui, R Burikhanov, S Gupta, S Satishkumar, S Shajahan, ... Cancer research 67 (24), 11811-11820, 2007 | 158 | 2007 |
| Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose? S Demaria, C Guha, J Schoenfeld, Z Morris, A Monjazeb, A Sikora, ... Journal for immunotherapy of cancer 9 (4), 2021 | 156 | 2021 |
| Concurrent PD-1 blockade negates the effects of OX40 agonist antibody in combination immunotherapy through inducing T-cell apoptosis RK Shrimali, S Ahmad, V Verma, P Zeng, S Ananth, P Gaur, RM Gittelman, ... Cancer immunology research 5 (9), 755-766, 2017 | 149 | 2017 |
| MEK inhibition reprograms CD8+ T lymphocytes into memory stem cells with potent antitumor effects V Verma, N Jafarzadeh, S Boi, S Kundu, Z Jiang, Y Fan, J Lopez, ... Nature Immunology 22 (1), 53-66, 2021 | 128 | 2021 |
| EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells. M Zagurovskaya, MM Shareef, A Das, A Reeves, S Gupta, M Sudol, ... Oncogene 28 (8), 1121-31, 2009 | 124 | 2009 |
| In Vivo Effects of Lattice Radiation Therapy on Local and Distant Lung Cancer: Potential Role of Immunomodulation S Kanagavelu, S Gupta, X Wu, S Philip, MM Wattenberg, JW Hodge, ... Radiation research 182 (2), 149-162, 2014 | 120 | 2014 |
| On modern technical approaches of three-dimensional high-dose lattice radiotherapy (LRT) X Wu, MM Ahmed, J Wright, S Gupta, A Pollack Cureus 2 (3), 2010 | 77 | 2010 |
| T-regulatory cells in tumor progression and therapy A Verma, R Mathur, A Farooque, V Kaul, S Gupta, BS Dwarakanath Cancer management and research 11, 10731, 2019 | 75 | 2019 |
| Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells S Gupta, T Koru-Sengul, SM Arnold, GR Devi, M Mohiuddin, MM Ahmed Molecular cancer therapeutics 10 (2), 292-302, 2011 | 65 | 2011 |
| Downregulation of PAR‐4, a pro‐apoptotic gene, in pancreatic tumors harboring K‐ras mutation MM Ahmed, D Sheldon, MA Fruitwala, K Venkatasubbarao, EY Lee, ... International journal of cancer 122 (1), 63-70, 2008 | 58 | 2008 |
| Cellular uptake, localization and photodynamic effects of haematoporphyrin derivative in human glioma and squamous carcinoma cell lines S Gupta, BS Dwarakanath, K Muralidhar, V Jain Journal of photochemistry and photobiology B: Biology 69 (2), 107-120, 2003 | 56 | 2003 |
| Enhancement of radiation and chemotherapeutic drug responses by 2-deoxy-D-glucose in animal tumors S Gupta, A Farooque, JS Adhikari, S Singh, BS Dwarakanath Journal of cancer research and therapeutics 5 (Suppl 1), S16-S20, 2009 | 45 | 2009 |
| The glycolytic inhibitor 2-deoxy-D-glucose enhances the efficacy of etoposide in Ehrlich ascites tumor bearing mice S Gupta, R Mathur, B Dwarakanath Cancer biology & therapy 4 (1), 94-101, 2005 | 40 | 2005 |
| Potential utilization of bystander/abscopal-mediated signal transduction events in the treatment of solid tumors ME Peters, MM Shareef, S Gupta, M Zagurovskaya-Sultanov, M Kadhim, ... Current signal transduction therapy 2 (2), 129-143, 2007 | 39 | 2007 |
| Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY) S Tubin, S Gupta, M Grusch, HH Popper, L Brcic, ML Ashdown, SN Khleif, ... Cancers 13 (1), 50, 2021 | 35 | 2021 |
| Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo L Agoni, I Basu, S Gupta, A Alfieri, A Gambino, GL Goldberg, EP Reddy, ... International Journal of Radiation Oncology* Biology* Physics 88 (5), 1180-1187, 2014 | 31 | 2014 |
Mansoor M AhmedNCI在 mail.nih.gov 的电子邮件经过验证
